Shares have also pushed higher at Inverness Medical Innovations (NYSE:IMA - News). On April 28 it said its test can identify H1N1. In addition, Chief Executive Ron Zwanziger recently said the company has inventory and can raise output as needed.
Inverness shares gained 17% over a four-session period following the swine flu news but were down in midday trading Friday.
While these companies can identify H1N1, they are aiming at a moving target, says Albert Wertheimer, director of the Center for Pharmaceutical Health Services Research at Temple University School of Pharmacy.
BTA Price at posting:
$1.49 Sentiment: Hold Disclosure: Held
